ABSI(Absci Corporation) · 财务报表

ABSI(Absci Corporation) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$4.78M$5.75M$5.72M$4.53M$2.80M
毛利润—————
营业利润−$75.24M−$106.75M−$115.52M−$108.89M−$120.32M
净利润−$100.96M−$104.90M−$110.57M−$103.11M−$115.18M
经营现金流−$60.60M−$81.34M−$64.64M−$72.40M−$92.92M
自由现金流−$98.64M−$97.51M−$65.50M−$72.81M−$94.03M
摊薄每股收益$-2.08$-1.15$-1.20$-0.94$-0.84

Absci Corporation ABSI